ArticlePatient preference and adherence2026
Patient Expectations, Safety Concerns, and Adherence to Topical Acne Medications: Findings from a Web-Based Survey.
Article in Patient preference and adherence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Suboptimal adherence to first-line topical medications (eg, topical retinoids, benzoyl peroxide, and topical antibiotics) is a major barrier to effective acne vulgaris (AV) management. The influence of patients' pre-treatment expectations and concerns about adverse effects on adherence behavior remains inadequately quantified. Objective: To evaluate young patients' perceptions of acne and their expectations, concerns, and adherence regarding topical medications. Methods: A web-based cross-sectional survey was conducted from December 2023 to January 2024. Patients aged 16-29 with a history of AV and topical medication use were recruited. Data on demographics, disease perception, medication knowledge, usage patterns, and adherence were collected via a structured questionnaire and analyzed using descriptive and comparative statistics. Results: A total of 501 valid questionnaires were collected. Patients acquired their knowledge about acne through various channels, with dermatologists being the most reliable source of information. Although 82.83% of patients recognized AV as a chronic disease, substantial misconceptions regarding its etiology and treatment persisted. Topical medications were commonly used, most frequently adapalene (40.92%), tretinoin (32.93%), benzoyl peroxide (24.75%), and clindamycin (20.96%). However, patients demonstrated limited knowledge regarding the proper application. Expectations for the onset of topical medications were overly optimistic, whereas the actual duration of use was often inadequate. The information that respondents had the strongest desire to access included the side effects, method of use, onset time, and duration of use. Medication discontinuation was primarily attributed to perceived slow efficacy or concerns about adverse effects, which contributed to a relatively high recurrence rate following treatment cessation. Conclusion: Young patients demonstrated limited comprehension of AV and lacked knowledge of topical medications and their appropriate application, as well as unrealistic expectations regarding onset time. Enhanced education on the nature of AV, along with detailed instructions on topical medication use, is crucial for improving patients' disease awareness and treatment adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.